3566 related articles for article (PubMed ID: 6769187)
1. HLA antigens in malignant melanoma patients.
Pellegris G; Illeni MT; Vaglini M; Rovini D; Cascinelli N; Masserini C
Tumori; 1980 Feb; 66(1):51-8. PubMed ID: 6769187
[TBL] [Abstract][Full Text] [Related]
2. HLA antigen frequencies in malignant melanoma patients. A second study.
Rovini D; Sacchini V; Codazzi V; Vaglini M; Illeni MT
Tumori; 1984 Feb; 70(1):29-33. PubMed ID: 6608815
[TBL] [Abstract][Full Text] [Related]
3. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
4. HLA and DR antigen frequencies in melanoma patients: possible relation to disease prognosis.
Pollack MS; Livingston PO
Tissue Antigens; 1985 Oct; 26(4):262-5. PubMed ID: 3878014
[TBL] [Abstract][Full Text] [Related]
5. HLA antigens in familial and sporadic cutaneous melanoma.
Rovini D; Pellegris G; Cascinelli N; Cantoni L; Vaglini M; Placucci M; Santinami M; Belli F; Illeni MT
Tumori; 1988 Dec; 74(6):657-64. PubMed ID: 3232210
[TBL] [Abstract][Full Text] [Related]
6. HLA associations in the antitumor response against malignant melanoma.
Marincola FM; Shamamian P; Rivoltini L; Salgaller M; Cormier J; Restifo NP; Simonis TB; Venzon D; White DE; Parkinson DR
J Immunother Emphasis Tumor Immunol; 1995 Nov; 18(4):242-52. PubMed ID: 8680652
[TBL] [Abstract][Full Text] [Related]
7. Expression of embryonic and MHC antigens in heterokaryons of murine embryonal carcinoma and human melanoma cells.
den Boer WC; van der Kamp AW; Mulder MP
Exp Cell Res; 1984 Sep; 154(1):25-37. PubMed ID: 6432568
[TBL] [Abstract][Full Text] [Related]
8. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
9. Loss of polymorphic restriction fragments of class I and class II MHC genes in a malignant melanoma.
Angelini G; Fossati G; Radice P; Longo A; Piccioli P; Pierotti MA; Ferrara GB; Parmiani G
J Immunogenet; 1986; 13(2-3):241-6. PubMed ID: 2880915
[TBL] [Abstract][Full Text] [Related]
10. Normal HLA class I, II, and MICA gene distribution in uveal melanoma.
Metzelaar-Blok JA; Hurks HM; Naipal A; De Lange P; Keunen JE; Claas FH; Doxiadis II; Jager MJ
Mol Vis; 2005 Dec; 11():1166-72. PubMed ID: 16379028
[TBL] [Abstract][Full Text] [Related]
11. HLA complex and familial malignant melanoma.
Pellegris G; Illeni MT; Rovini D; Vaglini M; Cascinelli N; Ghidoni A
Int J Cancer; 1982 Jun; 29(6):621-3. PubMed ID: 6955289
[TBL] [Abstract][Full Text] [Related]
12. Strong association between an HLA-DR antigen and thyroid carcinoma.
Panza N; Del Vecchio L; Maio M; De Felice M; Lombardi G; Minozzi M; Zappacosta S
Tissue Antigens; 1982 Aug; 20(2):155-8. PubMed ID: 6814009
[TBL] [Abstract][Full Text] [Related]
13. HLA antigens in malignant melanoma.
Bergholtz B; Brennhovd I; Klepp O; Kaakinen A; Thorsby E
Prog Clin Biol Res; 1977; 16():175-80. PubMed ID: 905323
[TBL] [Abstract][Full Text] [Related]
14. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA
J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040
[TBL] [Abstract][Full Text] [Related]
15. Possible relation between HLA and ABO type and prognosis of uveal melanoma.
Jager MJ; Völker-Dieben HJ; de Wolff-Rouendaal D; Kakebeeke-Kemme H; D'Amaro J
Doc Ophthalmol; 1992; 82(1-2):43-7. PubMed ID: 1305026
[TBL] [Abstract][Full Text] [Related]
16. Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression.
Wang Z; Margulies L; Hicklin DJ; Ferrone S
Tissue Antigens; 1996 May; 47(5):382-90. PubMed ID: 8795138
[TBL] [Abstract][Full Text] [Related]
17. Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific.
Versteeg R; Krüse-Wolters KM; Plomp AC; van Leeuwen A; Stam NJ; Ploegh HL; Ruiter DJ; Schrier PI
J Exp Med; 1989 Sep; 170(3):621-35. PubMed ID: 2788705
[TBL] [Abstract][Full Text] [Related]
18. Regional enteritis: evidence for genetic transmission by HLA typing.
Schwartz SE; Siegelbaum SP; Fazio TL; Hubbell C; Henry JB
Ann Intern Med; 1980 Sep; 93(3):424-7. PubMed ID: 7436159
[TBL] [Abstract][Full Text] [Related]
19. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
[TBL] [Abstract][Full Text] [Related]
20. Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A.
Howson JM; Walker NM; Clayton D; Todd JA;
Diabetes Obes Metab; 2009 Feb; 11 Suppl 1(Suppl 1):31-45. PubMed ID: 19143813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
